Migraines and Headaches in Mast Cell Activation Syndrome (MCAS)

Mast Cell Activation Syndrome (MCAS) is a condition in which mast cells, a type of immune cell, are overly reactive and release various chemicals like histamine and cytokines inappropriately. This overactivation can trigger a wide range of symptoms, particularly those affecting the nervous system. Among the most common neurological symptoms associated with MCAS are headaches, including migraines, which can range from mild to severe.

MCAS headaches occur due to the release of inflammatory mediators such as histamine, prostaglandins, and cytokines, which lead to vasodilation (widening of blood vessels) and inflammation in the brain. This process is thought to play a significant role in both headaches and migraines.

The Difference Between Migraines and Headaches in MCAS

It is important to differentiate between a regular headache and a migraine, as the two are distinct in nature and severity, especially for those managing MCAS.

What Is a Headache?

A headache is a broad term that describes any form of discomfort or pain in the head or face. The pain can be mild, moderate, or severe, and may result from a variety of causes including stress, dehydration, or poor posture. The most common types of headaches include:

• Tension headaches: Often described as a dull, aching pain or tightness, usually around the forehead or the back of the head. They are often triggered by stress or muscle tension and can last for minutes to hours.
• Cluster headaches: Severe headaches that occur in cyclical patterns or "clusters." These typically cause intense pain around one eye and may last for weeks or months.

In MCAS, headaches are often triggered by the release of histamine and other inflammatory mediators, leading to blood vessel dilation in the brain. These headaches may be dull or throbbing but are generally less intense than migraines.

What Is a Migraine?

A migraine is a specific type of headache that involves more than just pain. Migraines are usually more severe, with throbbing or pulsating pain that often affects one side of the head. Migraines may last for hours or even days and are often accompanied by additional symptoms such as:

• Nausea and vomiting
• Sensitivity to light, sound, or smells
• Visual disturbances such as flashing lights or blind spots (aura)
• Dizziness or vertigo

In MCAS, migraines are thought to be triggered by the activation of mast cells located near nerves and blood vessels in the brain. The release of inflammatory mediators, including histamine, prostaglandins, and neuropeptides like substance P and CGRP (calcitonin gene-related peptide), contributes to the intense pain and additional symptoms associated with migraines.

Key Differences Between Migraines and Headaches

• Intensity: Headaches tend to be milder than migraines. Migraines are usually severe, causing throbbing or pulsating pain.
• Location: While headaches can affect the entire head or specific areas like the forehead, migraines are typically one-sided.
• Associated Symptoms: Migraines often come with nausea, vomiting, and sensitivity to light and sound, which are not typically present with standard headaches.
• Duration: Migraines can last for hours or even days, while headaches, particularly tension headaches, often resolve within a few hours.

MCAS and Neurological Symptoms

In addition to headaches and migraines, MCAS can cause a variety of other neurological symptoms due to the release of mast cell mediators affecting both the central and peripheral nervous systems. These symptoms include:

• Cognitive dysfunction: Often described as "brain fog," patients may have difficulty concentrating or experience memory issues.
• Dizziness and vertigo: These are commonly linked to mast cell activation in the inner ear or the autonomic nervous system.
• Tingling or numbness: Some patients report abnormal sensations in their limbs, which could be due to peripheral neuropathy (nerve dysfunction).

Because mast cells reside near nerves and blood vessels in the brain, the chemicals they release can cause widespread neurological effects, including exacerbating headaches and migraines.

Mast Cell Activation Syndrome and Migraines

Migraines are particularly common in patients with MCAS and are linked to mast cell overactivity in the dura mater, the membrane surrounding the brain. This leads to the release of several inflammatory mediators, which contribute to migraine development:

• Histamine and Other Mediators: Histamine causes blood vessels to dilate, leading to inflammation in the brain that triggers migraine pain. Prostaglandins and cytokines further enhance the inflammatory response.
• Activation by Stress and Allergens: Triggers like stress, allergens, or certain foods can activate mast cells, which then release chemicals that can cause or worsen migraines.
• Role of Neuropeptides: Neuropeptides such as CGRP and substance P are involved in the activation of mast cells and play a significant role in the development of migraines.

Managing Headaches in MCAS

Effective management of MCAS-related headaches and migraines typically focuses on reducing mast cell activation and controlling the release of inflammatory mediators. Here are some key strategies:

• Antihistamines: H1 blockers (such as loratadine) and H2 blockers (such as famotidine) are often prescribed to lower histamine levels and alleviate symptoms.
• Mast Cell Stabilizers: Medications like cromolyn sodium and ketotifen can help prevent the release of mediators from mast cells.
• Low-Histamine Diet: Avoiding foods high in histamine, like aged cheeses, cured meats, and fermented foods, may reduce the frequency and intensity of headaches.
• Avoidance of Triggers: Identifying and avoiding triggers, whether they are food-based, environmental, or related to stress, is crucial in managing symptoms.

Conclusion

MCAS can have a profound effect on the nervous system, contributing to both headaches and migraines. The inappropriate release of histamine and other mast cell mediators plays a significant role in these neurological symptoms, particularly in migraine development. By employing targeted treatments such as antihistamines, mast cell stabilizers, and lifestyle modifications, many MCAS patients can successfully manage their symptoms and improve their quality of life.

‍

FAQ

Can mast cell activation syndrome cause migraines?
Yes, MCAS can cause migraines. Mast cells in the brain can release histamine and other inflammatory mediators, which lead to vasodilation and inflammation of blood vessels, contributing to migraine symptoms.

Can high histamine cause migraines?
Yes, high histamine levels can trigger migraines by causing blood vessels in the brain to expand, leading to inflammation and intense headache pain.

What are the neurological symptoms of MCAS?
Neurological symptoms of MCAS can include headaches, migraines, cognitive dysfunction ("brain fog"), dizziness, tingling or numbness, and in some cases, peripheral neuropathy.

How do you treat MCAS headaches?
MCAS headaches are typically treated with a combination of antihistamines (H1 and H2 blockers), mast cell stabilizers (like cromolyn sodium), and dietary modifications, such as following a low-histamine diet. Avoiding known triggers is crucial.

What are the weird symptoms of MCAS?
MCAS can cause unusual symptoms like random flushing, sensitivity to smells or chemicals, digestive issues, itching without a rash, light-headedness, and sudden temperature changes. Many symptoms can be confusing and mimic other conditions.

Do antihistamines help migraines?
Yes, antihistamines can help manage migraines in MCAS by reducing histamine levels, which are a key factor in triggering migraine pain and other symptoms.

What does histamine overload feel like?
Histamine overload can cause symptoms like headaches, flushing, hives, itching, nasal congestion, abdominal pain, and heart palpitations. In severe cases, it can lead to dizziness, anxiety, and digestive discomfort.

How do you stop histamine headaches?
Histamine headaches can be managed by using antihistamines (both H1 and H2 blockers), following a low-histamine diet, and avoiding known triggers. In some cases, mast cell stabilizers may also help prevent histamine release.

What can be mistaken for MCAS?
Conditions like fibromyalgia, chronic fatigue syndrome, irritable bowel syndrome (IBS), Migraine, allergies, and even autoimmune disorders can be mistaken for MCAS due to overlapping symptoms.

What is the new treatment for MCAS?
While there is no single new treatment, advances in MCAS management include the use of biologics like omalizumab (an anti-IgE monoclonal antibody) and CGRP inhibitors, which have shown promise in reducing mast cell activation and related symptoms.

‍

‍

‍

References

1. Theoharides, T.C., Donelan, J., Kandere-Grzybowska, K., Konstantinidou, A. (2005). The role of mast cells in migraine pathophysiology. Brain Research Reviews, 49(1), 65-76. https://doi.org/10.1016/j.brainresrev.2004.11.006.
2. Seneviratne, S.L., Maitland, A., Afrin, L. (2017). Mast cell disorders in Ehlers-Danlos syndrome. American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 175C(1), 226-236. https://doi.org/10.1002/ajmg.c.31555.
3. Chopra, P., Tinkle, B., Hamonet, C., Brock, I., Gompel, A., Bulbena, A., Francomano, C. (2017). Pain management in the Ehlers–Danlos syndromes. American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 175C(1), 212-219. https://doi.org/10.1002/ajmg.c.31554.
4. Molderings, G.J., Haenisch, B., Brettner, S., Homann, J., Menzen, M., Dumoulin, F.L., Panse, J., Butterfield, J.H., Afrin, L.B. (2016). Pharmacological treatment options for mast cell activation disease. Naunyn-Schmiedeberg's Archives of Pharmacology, 389, 671-694. https://doi.org/10.1007/s00210-016-1247-1.

‍